← Open Payments lookup

MARISA LIANG: Open Payments

NPI 1154712933 · GILROY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$969 in 16 payments from 10 companies in 2025. Trend: 2023 $187 · 2024 $1,150 · 2025 $969

Food & beverage: $969
CompanyPaymentsAmount
Ascendis Pharma Endocrinology Inc3$265
Amgen Inc.3$255
Lilly USA, LLC2$107
Corcept Therapeutics1$105
BETA BIONICS, INC.1$89
AstraZeneca Pharmaceuticals LP1$55
Novo Nordisk Inc2$32
Madrigal Pharmaceuticals1$24
Insulet Corporation1$23
Novartis Pharmaceuticals Corporation1$15

Products named: Yorvipath, REPATHA, Korlym, iLet Bionic Pancreas, ZEPBOUND, MOUNJARO, REZDIFFRA, Omnipod.

Industry payments across CA — which companies pay providers there.